《本草纲目·百病主治药》研究述评  

Review on the research of Compendium of Materia Medica:Indicative Medicines for Various Diseases

作　　者：林艳华 宋咏梅 LIN Yanhua;SONG Yongmei(Institute of Chinese Medical Literature and Culture,Shandong University of Traditional Chinese Medicine,Jinan 250355,China)

机构地区：[1]山东中医药大学中医文献与文化研究院,济南250355

出　　处：《中华中医药杂志》2024年第2期985-988,共4页China Journal of Traditional Chinese Medicine and Pharmacy

基　　金：2020年中医药古籍文献和特色技术传承专项项目(No.GZY-KJS-2020-029)。

摘　　要：“百病主治药”位于《本草纲目》第三、四卷,是李时珍对历代医家辨病与辨证选药精华的总结,有重要的临床应用价值和文献价值。以往对《本草纲目》的研究以药物各论为主,对“百病主治药”的研究较少。近年来,学者对其重视度日益提高,因此文章对“百病主治药”研究成果和存在的问题进行论述,望为日后此部分的研究提供参考。Located in volumes II and V of the Compendium of Materia Medica,the'indicative medicines for various diseases'was LI Shizhen's summary of the essence of disease differentiation and drug selection by doctors in previous dynasties.It has important clinical application value and literature value.In the past,the research on Compendium of Materia Medica mainly focused on the various theories of drugs,and the research on'indicative medicines for various diseases'was less.In recent years,scholars have paid more and more attention to it.Therefore,this paper discusses the research results and existing problems of'indicative medicines for various diseases',hoping to provide reference for future research in this part.

关 键 词：《本草纲目》 百病主治药 诸疾通用药 进展 文献研究 以病类药 价值 

分 类 号：R281.3[医药卫生—中药学]